Adverse outcomes among Aboriginal patients receiving peritoneal dialysis
Authors:
- Manish M. SoodMSManish M. Sood
- Paul KomendaPKPaul Komenda
- Amy R. SoodASAmy R. Sood
- Martina ReslerovaMRMartina Reslerova
- Mauro VerrelliMVMauro Verrelli
- Chris SathianathanCSChris Sathianathan
- Loretta EngLELoretta Eng
- Amanda EngAEAmanda Eng
- Claudio RigattoCRClaudio Rigatto
- 26 July 2010
- journal article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 182 (13) , 1433-1439
Abstract
Background: The Aboriginal population in Canada experiences high rates of end-stage renal disease and need for dialytic therapies. Our objective was to examine rates of mortality, technique failure and peritonitis among adult aboriginal patients receiving peritoneal dialysis in the province of Manitoba. We also aimed to explore whether differences in these rates may be accounted for by location of residence (i.e., urban versus rural). Methods: We included all adult patients residing in the province of Manitoba who received peritoneal dialysis during the period from 1997–2007 (n = 727). We extracted data from a local administrative database and from the Canadian Organ Replacement Registry and the Peritonitis Organism Exit-sites/Tunnel infections (POET) database. We used Cox and logistic regression models to determine the relationship between outcomes and Aboriginal ethnicity. We performed Kaplan–Meier analyses to examine the relationship between outcomes and urban (i.e., 50 km or less from the primary dialysis centre in Winnipeg) versus rural (i.e., more than 50 km from the centre) residency among patients who were aboriginal. Results: One hundred sixty-one Aboriginal and 566 non-Aboriginal patients were included in the analyses. Adjusted hazard ratios for mortality (HR 1.476, CI 1.073–2.030) and adjusted time to peritonitis (HR 1.785, CI 1.352–2.357) were significantly higher among Aboriginal patients than among non-Aboriginal patients. We found no significant differences in mortality, technique failure or peritonitis between urban- or rural-residing Aboriginal patients. Interpretation: Compared with non-Aboriginal patients receiving peritoneal dialysis, Aboriginal patients receiving peritoneal dialysis had higher mortality and faster time to peritonitis independent of comorbidities and demographic characteristics. This effect was not influenced by place of residence, whether rural or urban.Keywords
This publication has 28 references indexed in Scilit:
- Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 casesBMC Nephrology, 2009
- Predictors of Peritonitis in Patients on Peritoneal DialysisClinical Journal of the American Society of Nephrology, 2009
- Pseudomonas Peritonitis in AustraliaClinical Journal of the American Society of Nephrology, 2009
- Impact of Age on Peritonitis Risk in Peritoneal Dialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Relationship between Dialysis Modality and MortalityJournal of the American Society of Nephrology, 2009
- Prevalence of Chronic Kidney Disease and Survival among Aboriginal PeopleJournal of the American Society of Nephrology, 2007
- Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysisCanadian Medical Association Journal, 2007
- Mortality of Canadians treated by peritoneal dialysis in remote locationsKidney International, 2007
- Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zealand Peritoneal Dialysis Patient PopulationsJournal of the American Society of Nephrology, 2006
- Use and Outcomes of Peritoneal Dialysis among Aboriginal People in CanadaJournal of the American Society of Nephrology, 2005